Introduction {#s1}
============

Duodenal ulcer (DU), a major peptic ulcer, is defined as a disorder of mucosal defects in the duodenum. DU patients exhibit gastrointestinal symptoms such as abdominal pain, discomfort, nausea, and an episode of melena. *Helicobacter pylori* (*H. pylori*) infection is a major cause of DU and the eradication of *H. pylori* is essential to prevent the development of DU ([@B1]). In the duodenal bulb, anterior ulcers are common, with Kang et al. reporting that recurrent DUs were more likely to occur in the anterior region ([@B2]). While antiulcer drugs are the first choice of therapy, surgical and endoscopic therapies are additionally adopted in perforated or bleeding DU cases ([@B3], [@B4]). Although relatively common in adults, DU is rare in pediatric cases.

An upper gastroscopy is needed for diagnosis. However, it requires professional skills. Most patients undergo additional screening tests such as the fecal occult blood test (FOBT), X-ray, and/or computed tomography (CT); however, the latter two are associated with radiation exposure risks. It is reported that the FOBT is not useful for diagnosing DU ([@B5]).

Due to improvements in ultrasonic equipment, high resolution images can be obtained; therefore, several studies have used ultrasound sonography (US) to report the diagnostic utility of the hypertrophic wall of the duodenal bulb with its central echoic line in adult DU cases ([@B6], [@B7]). However, pediatric cases have received little attention ([@B8]). In this study, using US, we aimed to evaluate the hypertrophic wall of the duodenal bulb with a hyperechoic lumen (hereafter designated as the "HH sign") as a potential diagnostic marker for DU in five pediatric patients.

Methods {#s2}
=======

Patients
--------

Our study was a single center, retrospective case series. The subjects were five patients: three men and two women, aged between 11 and 14 years (mean age: 12.5 years), who were presented to the Tokuyama Central Hospital (Yamaguchi, Japan) between 2007 and 2017. Clinical features of these patients are shown in [Table 1](#T1){ref-type="table"}. This study was conducted in accordance with the recommendations of Institutional Review Board of Tokuyama Central Hospital. The protocol was approved by the Institutional Review Board of Tokuyama Central Hospital (K346-20190807). All subjects gave written informed consent in accordance with the Declaration of Helsinki.

###### 

Clinical features of patients.

                                                       **On admission**                              
  --- ---- --- -------------------------------- ------ ------------------ ------ -------- ---------- -------------------
  1   14   F   Abdominal pain                   None   11970              14.5   0.56     Negative   Perforated DU
  2   13   M   Upper abdominal pain             Two    7420               8.6    1.25     Negative   Non-perforated DU
  3   12   F   Upper abdominal pain             Four   7370               13.0   0.17     Negative   Not done
  4   11   M   Upper abdominal pain             None   6400               13.8   \<0.02   Negative   Not done
  5   13   M   Upper abdominal pain Dizziness   None   8500               9.2    \<0.02   Positive   Unremarkable

*Age at diagnosis; F, female; M, male; CT, computed tomography; WBC, white blood cells; Hb, hemoglobin; CRP, C-reactive protein; DU, duodenal ulcer*.

Diagnostic Procedures
---------------------

The US equipment used in this study included the Xario SSA-650A and Aplio400 from Canon Medical Systems Corporation (Tochigi, Japan), with convex (3.5, 6 MHz) and linear (8, 10 MHz) transducers. The liver, gallbladder, kidneys, pancreas, spleen, the gastrointestinal tract (gastroduodenal region, small intestine, colon, and rectum), and the aorta with its branches (such as the celiac and superior mesenteric arteries) were evaluated by US. CT was performed in three patients, and the FOBT was performed in all patients. DU was confirmed by upper gastroscopy in all cases. All patients underwent a proper treatment for DU, including the administration of proton pump inhibitors. *H. pylori* infection was confirmed in all cases. An antibiotic agent was administered to the patient with perforated DU, and an eradication therapy for *H. pylori* was adopted in all patients.

Diagnostic Criteria
-------------------

The duodenum was identified in the epigastric or right hypochondriac region. A normal image of the duodenal bulb shows three layers: the hyperechoic inner and outer layers and a hypoechoic middle layer ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). The HH sign was determined to be the sonographic criterion of a DU, consisting of duodenal wall hypertrophy with thickness ≥5 mm, along with the central hyperechoic line.

Results {#s3}
=======

Case 1
------

A 14-year-old girl was admitted to our hospital with sudden abdominal pain. Diffuse tenderness with abdominal guarding was observed on admission. The body height (BH) and body weight (BW) were 157 centimeters (cm) and 49.0 kilograms (kg) on admission, respectively. A blood test revealed slightly elevated counts of white blood cells (WBC: 12.0 ×10^9^/L) and C reactive protein (CRP: 0.56 mg/dL, reference range: ≤ 0.3 mg/dL), and the FOBT was negative ([Table 1](#T1){ref-type="table"}). We performed an abdominal sonography, which revealed peritoneal fluid accumulation and the HH sign in the duodenal bulb ([Figure 1A](#F1){ref-type="fig"}). CT revealed edematous changes and wall defects in the duodenal bulb, which indicated a perforated DU. An antiulcer drug and antibiotic agent were administered, with concomitant fasting. Eight days after admission, we performed an endoscopy and identified ulceration in the duodenal bulb, on the basis of which, the patient was diagnosed with DU.

![**(A)** Case 1, **(B)** Case 2, **(C)** Case 3, and **(D)** Case 4. The HH sign---extensive hyperplasia of the duodenal wall (white arrows) and the hyperechoic inner layer (white head-arrow)---was observed. The peritoneal fluid (\*) is identified in case 1.](fped-07-00547-g0001){#F1}

Case 2
------

A 13-year-old boy was presented to our hospital with upper abdominal pain lasting for 3 months. The BH and BW were 151.5 cm and 40.4 kg on admission, respectively. A blood test revealed anemia (hemoglobin 8.6 g/dL) with a slight elevation of CRP level (1.25 mg/dL), and the FOBT was negative ([Table 1](#T1){ref-type="table"}). An abdominal US scan revealed the presence of the HH sign ([Figure 1B](#F1){ref-type="fig"}) and the absence of free air and ascites that usually indicate a perforated DU. CT revealed wall hyperplasia in the duodenal bulb, consistent with a DU. An endoscopy revealed a microhemorrhage in the anteriorly located DU. Five days after the initiation of the antiulcer drug, we performed a US and found that the HH sign had diminished (data not shown). He experienced two recurrent episodes, and in both, the HH sign, which was observed in the symptomatic period, diminished in the post-treatment period ([Figure 2A](#F2){ref-type="fig"}).

![**(A)** Case 2 and **(B)** Case 3. The sonographic images in the recurrent episode are shown. The hypertrophic wall and echogenic line (HH sign) are shown in "Pre." The HH sign diminished on treatment with the antiulcer drug (arrows) as shown in "Post." Pre, pretreatment; Post, post-treatment with antiulcer agent.](fped-07-00547-g0002){#F2}

Case 3
------

A 12-year-old girl suffering from upper abdominal pain for several months was presented to our hospital. The BH and BW were 150 cm and 39.4 kg on admission, respectively. Her blood tests were normal (WBC 7.4 ×10^9^/L, hemoglobin 13.0 g/dL, CRP 0.17 mg/dL), and the FOBT was negative ([Table 1](#T1){ref-type="table"}). A US scan revealed the HH sign in the right epigastric region, consistent with her symptomatic site ([Figure 1C](#F1){ref-type="fig"}). An endoscopy revealed DU on the anterior wall of the duodenal bulb. After the first episode, she experienced four recurrent episodes. In each, a pretreatment US scan revealed the HH sign, which disappeared in response to the treatment ([Figure 2B](#F2){ref-type="fig"}).

Case 4
------

An 11-year-old boy was hospitalized for epigastric pain. The BH and BW were 133 cm and 34.6 kg on admission, respectively. The thickness of the duodenal bulb wall was 5.4 mm (which slightly exceeded the 5 mm limit) and the hyperechoic line was clearly visible, consistent with the HH sign ([Figure 1D](#F1){ref-type="fig"}). Blood tests were normal (WBC 6.4 ×10^9^/L, hemoglobin 13.8 g/dL, CRP \<0.02 mg/dL), and the FOBT was negative ([Table 1](#T1){ref-type="table"}). We observed ulceration with highly mucosal edema, and the duodenal lumen was obstructed by the edematous change. The HH sign diminished after the initiation of the antiulcer drug (data not shown).

Case 5
------

A 13-year-old boy was presented to our hospital with complaints of dizziness and upper abdominal pain. On admission, the BH and BW were 153 cm and 38.3 kg, respectively. Blood testing revealed anemia (hemoglobin 9.2 g/dL), and the FOBT was positive ([Table 1](#T1){ref-type="table"}). Since melena was observed on hospitalization, we performed a US, which revealed a mass-like region surrounded by a blood vessel ([Figures 3A,B](#F3){ref-type="fig"}) that appeared to be connected to the duodenum. The HH sign was not observed. No remarkable findings were found in the CT image. In the endoscopy, the ulcer was identified at a site between the anterior and posterior bulb. A US performed 20 days after treatment revealed that the mass-like lesion disappeared.

![**(A)** The tumor-like region is identified (white arrow), which is located as part of the DU. **(B)** The blood vessel around the region and the central echogenic line (appearing to be the mucosa) are visualized. D, duodenum; P, pancreas; AO, aorta; IVC, inferior vena cava; SMA; superior mesenteric artery; V, vertebral column.](fped-07-00547-g0003){#F3}

Discussion {#s4}
==========

Our study aimed to investigate whether the HH sign is a useful US finding for diagnosing pediatric DU cases. This sign was observed in four of the five pediatric DU cases. CT analysis performed in three cases revealed ulceration in two. Although the FOBT was performed in all cases, it was positive only in one. Our findings on US are compatible with previous reports in adult cases that showed that the HH sign was diagnostic for DU ([@B6], [@B7]). In previous reports, the presence of free air and variable amounts of free fluid were significant findings indicating perforated peptic ulcers ([@B9]--[@B11]). Free air is visualized as a reverberation, having a comet-tail appearance in the ultrasound ([@B9], [@B10]). Fam et al. ([@B11]) reported a case of a perforated DU with pneumoperitoneum, where air in the portal and systemic venous systems was confirmed by CT. In our study, in the patient with a perforated DU, there was no evidence of free air, but a relatively large amount of free fluid was revealed on US.

US, CT, FOBT, and upper gastroscopy are the commonly available screening tests for peptic ulcer, with some studies reporting the diagnostic utility of CT imaging for such ulcers in adult patients ([@B12], [@B13]). In our study, ulceration was observed in two of the three pediatric cases subjected to CT; however, Allen et al. ([@B13]) reported that the sensitivity of CT for non-perforated peptic ulcers was low and DUs were hardly identified compared to gastric ulcers. Further, radiation exposure is a matter of concern in children. Regarding acute radiation syndrome, it is reported that hematopoietic disorders are more likely to occur in children than in adults ([@B14]). Krille et al. ([@B15]) investigated the late effects of exposure to ionizing radiation from CT in a pediatric case, suggesting that this was a risk factor for a secondary cancer.

FOBT is commonly used to assess gastrointestinal diseases with bleeding. However, the Canadian Agency for Drugs and Technologies in Health states that its clinical effectiveness for diagnosis in patients with suspected gastrointestinal bleeding remains unknown ([@B16]). Nakama et al. ([@B5]) reported that the diagnostic sensitivity of FOBT was low in upper digestive tract diseases. This is in line with our observation, where that it was positive in only one case.

In general, endoscopy is mandatory for confirming DU, provides a local treatment in case of bleeding ulcer, and allows to perform biopsy samples for *H. pylori* diagnosis. Therefore, the interest of US could only be suggested in the patient with isolated epigastric pain showing no bleeding or growth retardation as endoscopy has to be performed irrespective of the US results in the cases with bleeding or other complication. Furthermore, the HH sign observed in recurrent episodes were reversible in case 2 and 3. Approximately 5 percent of DU patients is resistant to antiulcer drug and 20 percent of the patients relapses within 6 months after initial therapy ([@B17], [@B18]). US could be useful in the case of follow-up of DU patients with the recurrence risk because of its non-invasiveness.

The present study has several limitations. First, a US scan is dependent on the clinician\'s skill. Although a study reported that the sensitivity of US for the diagnosis of peptic ulcers in older children weighing \>30 kg was low ([@B8]), in our study, DUs were identified using US in four out of the five pediatric patients weighing \>30 kg. Additionally, factors such as bowel gas and obesity could negatively affect the examination. Second, the sample size was very small because pediatric DU patients are very rare and this study was a pilot study conducted in a single center. Further multi-center studies involving different regions are warranted to confirm the diagnostic utility of the HH sign in pediatric DU patients.

In conclusion, we showed that US identified the HH sign in four out of the five pediatric DU patients. The DU was located in the anterior bulb, a common site for these ulcers. Our findings suggest that this sign could be useful for the follow-up of pediatric DU.
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The normal image of duodenal bulb in the healthy child. This image shows three layer (white arrowhead) and especially the thickness of middle layer is thin.

###### 

Click here for additional data file.

HH sign

:   hypertrophic wall of duodenal bulb with a hyperechoic lumen.
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